MTA-304
Asset
Inhibition of phosphodiesterase 10A (PDE10A).
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- PDE10A
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Levodopa-induced dyskinesia in Parkinson's disease
Phase 2, prnewswire.com, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners2
- Evidence for its targets1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.